IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 61 filers reported holding IMMUNE DESIGN CORP in Q1 2017. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $277,000 | +354.1% | 47,386 | +0.9% | 0.00% | – |
| Q4 2018 | $61,000 | -47.0% | 46,946 | +41.0% | 0.00% | – |
| Q3 2018 | $115,000 | -24.3% | 33,286 | -0.7% | 0.00% | – |
| Q2 2018 | $152,000 | +78.8% | 33,511 | +29.6% | 0.00% | – |
| Q1 2018 | $85,000 | +32.8% | 25,863 | +57.7% | 0.00% | – |
| Q4 2017 | $64,000 | -68.9% | 16,398 | -17.5% | 0.00% | – |
| Q3 2017 | $206,000 | +7.3% | 19,869 | +0.9% | 0.00% | – |
| Q2 2017 | $192,000 | +120.7% | 19,694 | +53.9% | 0.00% | – |
| Q1 2017 | $87,000 | +29.9% | 12,798 | +5.3% | 0.00% | – |
| Q4 2016 | $67,000 | -16.2% | 12,151 | +15.7% | 0.00% | – |
| Q3 2016 | $80,000 | -2.4% | 10,499 | +4.1% | 0.00% | – |
| Q2 2016 | $82,000 | -39.3% | 10,089 | -3.1% | 0.00% | – |
| Q1 2016 | $135,000 | -35.4% | 10,416 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $209,000 | – | 10,416 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COLUMN GROUP L P | 3,161,942 | $65,294,000 | 100.00% |
| ProQuest Associates IV LLC | 1,983,858 | $40,967,000 | 8.41% |
| Iguana Healthcare Management, LLC | 150,000 | $3,098,000 | 0.98% |
| SECTORAL ASSET MANAGEMENT INC | 810,390 | $16,735,000 | 0.70% |
| Cormorant Asset Management, LP | 189,000 | $3,903,000 | 0.52% |
| SPHERA FUNDS MANAGEMENT LTD. | 140,000 | $2,891,000 | 0.28% |
| RS INVESTMENT MANAGEMENT CO LLC | 750,402 | $15,496,000 | 0.13% |
| Eventide Asset Management | 102,904 | $2,125,000 | 0.12% |
| Rock Springs Capital Management LP | 55,000 | $1,136,000 | 0.08% |
| Focused Wealth Management, Inc | 3,406 | $70,000 | 0.04% |